BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 25520826)

  • 1. The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response.
    Sawa T
    J Intensive Care; 2014; 2(1):10. PubMed ID: 25520826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review.
    Sawa T; Shimizu M; Moriyama K; Wiener-Kronish JP
    Crit Care; 2014 Dec; 18(6):668. PubMed ID: 25672496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
    Finck-Barbançon V; Goranson J; Zhu L; Sawa T; Wiener-Kronish JP; Fleiszig SM; Wu C; Mende-Mueller L; Frank DW
    Mol Microbiol; 1997 Aug; 25(3):547-57. PubMed ID: 9302017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia.
    Rangel SM; Logan LK; Hauser AR
    mBio; 2014 Jun; 5(3):e01080-14. PubMed ID: 24917597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ExoU is a potent intracellular phospholipase.
    Sato H; Frank DW
    Mol Microbiol; 2004 Sep; 53(5):1279-90. PubMed ID: 15387809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to virulence in the lung.
    Shaver CM; Hauser AR
    Infect Immun; 2004 Dec; 72(12):6969-77. PubMed ID: 15557619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The exoenzyme S regulon of Pseudomonas aeruginosa.
    Frank DW
    Mol Microbiol; 1997 Nov; 26(4):621-9. PubMed ID: 9427393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular targeting of exoenzyme S of Pseudomonas aeruginosa via type III-dependent translocation induces phagocytosis resistance, cytotoxicity and disruption of actin microfilaments.
    Frithz-Lindsten E; Du Y; Rosqvist R; Forsberg A
    Mol Microbiol; 1997 Sep; 25(6):1125-39. PubMed ID: 9350868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exoenzyme Y Contributes to End-Organ Dysfunction Caused by
    Wagener BM; Anjum N; Christiaans SC; Banks ME; Parker JC; Threet AT; Walker RR; Isbell KD; Moser SA; Stevens T; Alexeyev MF; Audia JP; Richter W; Hardy KS; Saleh LA; Morgan C; Pittet JF
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32512716
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis.
    Miyata S; Casey M; Frank DW; Ausubel FM; Drenkard E
    Infect Immun; 2003 May; 71(5):2404-13. PubMed ID: 12704110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system.
    Yahr TL; Vallis AJ; Hancock MK; Barbieri JT; Frank DW
    Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13899-904. PubMed ID: 9811898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system.
    Ader F; Le Berre R; Faure K; Gosset P; Epaulard O; Toussaint B; Polack B; Nowak E; Viget NB; Kipnis E; Guery BP
    Infect Immun; 2005 Jul; 73(7):4263-71. PubMed ID: 15972518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triggering the ExoS regulon of Pseudomonas aeruginosa: A GFP-reporter analysis of exoenzyme (Exo) S, ExoT and ExoU synthesis.
    Hornef MW; Roggenkamp A; Geiger AM; Hogardt M; Jacobi CA; Heesemann J
    Microb Pathog; 2000 Dec; 29(6):329-43. PubMed ID: 11095918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa causes acute lung injury via the catalytic activity of the patatin-like phospholipase domain of ExoU.
    Pankhaniya RR; Tamura M; Allmond LR; Moriyama K; Ajayi T; Wiener-Kronish JP; Sawa T
    Crit Care Med; 2004 Nov; 32(11):2293-9. PubMed ID: 15640644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Pseudomonas aeruginosa type III effectors in disease.
    Engel J; Balachandran P
    Curr Opin Microbiol; 2009 Feb; 12(1):61-6. PubMed ID: 19168385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients.
    Jabalameli F; Mirsalehian A; Khoramian B; Aligholi M; Khoramrooz SS; Asadollahi P; Taherikalani M; Emaneini M
    Burns; 2012 Dec; 38(8):1192-7. PubMed ID: 22995427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exoenzyme T of Pseudomonas aeruginosa elicits cytotoxicity without interfering with Ras signal transduction.
    Sundin C; Henriksson ML; Hallberg B; Forsberg A; Frithz-Lindsten E
    Cell Microbiol; 2001 Apr; 3(4):237-46. PubMed ID: 11298647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic relationship between the 53- and 49-kilodalton forms of exoenzyme S from Pseudomonas aeruginosa.
    Yahr TL; Barbieri JT; Frank DW
    J Bacteriol; 1996 Mar; 178(5):1412-9. PubMed ID: 8631719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.
    Feltman H; Schulert G; Khan S; Jain M; Peterson L; Hauser AR
    Microbiology (Reading); 2001 Oct; 147(Pt 10):2659-2669. PubMed ID: 11577145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection.
    Lee VT; Smith RS; Tümmler B; Lory S
    Infect Immun; 2005 Mar; 73(3):1695-705. PubMed ID: 15731070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.